Advisor Group Holdings, Inc. Celldex Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

$39.8 Billion
Q4 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 465 shares of CLDX stock, worth $9,244. This represents 0.0% of its overall portfolio holdings.

Number of Shares

465

Previous 491 5.3%

Holding current value

$9,244

Previous $16,000 31.25%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$23.31 - $32.4 $606 - $842	-26 Reduced 5.3%	465 $11,000
Q3 2024 Nov 13, 2024	SELL	$32.06 - $44.56 $6,347 - $8,822	-198 Reduced 28.74%	491 $16,000
Q2 2024 Aug 13, 2024	SELL	$32.76 - $42.56 $2,325 - $3,021	-71 Reduced 9.34%	689 $25,000
Q1 2024 May 10, 2024	BUY	$35.22 - $51.88 $7,501 - $11,050	213 Added 38.94%	760 $31,000
Q4 2023 Feb 12, 2024	SELL	$22.61 - $40.65 $3,301 - $5,934	-146 Reduced 21.07%	547 $21,000
Q3 2023 Nov 13, 2023	SELL	$25.45 - $37.46 $2,977 - $4,382	-117 Reduced 14.44%	693 $19,000
Q2 2023 Aug 10, 2023	SELL	$30.29 - $38.28 $2,968 - $3,751	-98 Reduced 10.79%	810 $27,000
Q1 2023 May 12, 2023	SELL	$34.78 - $47.43 $1,982 - $2,703	-57 Reduced 5.91%	908 $32,000
Q4 2022 Feb 10, 2023	SELL	$27.78 - $45.38 $1,916 - $3,131	-69 Reduced 6.67%	965 $43,000
Q3 2022 Nov 14, 2022	SELL	$22.7 - $37.57 $227 - $375	-10 Reduced 0.96%	1,034 $29,000
Q2 2022 Aug 10, 2022	BUY	$20.5 - $37.33 $1,353 - $2,463	66 Added 6.75%	1,044 $28,000
Q1 2022 May 04, 2022	BUY	$27.64 - $39.32 $1,824 - $2,595	66 Added 7.24%	978 $32,000
Q3 2021 Nov 05, 2021	SELL	$28.95 - $55.99 $289 - $559	-10 Reduced 1.08%	912 $49,000
Q1 2021 May 13, 2021	SELL	$16.19 - $29.91 $210 - $388	-13 Reduced 1.39%	922 $18,000
Q4 2020 Feb 10, 2021	SELL	$14.99 - $22.75 $5,981 - $9,077	-399 Reduced 29.91%	935 $16,000
Q3 2020 Nov 12, 2020	BUY	$9.65 - $15.19 $125 - $197	13 Added 0.98%	1,334 $20,000
Q2 2020 Aug 14, 2020	BUY	$1.61 - $13.41 $590 - $4,921	367 Added 38.47%	1,321 $17,000
Q1 2020 May 18, 2020	BUY	$1.55 - $3.07 $1,478 - $2,928	954 New	954 $1,000

Others Institutions Holding CLDX

# of Institutions

197

Shares Held

69.7M

Call Options Held

960K

Put Options Held

675K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $930M
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Celldex Therapeutics, Inc. Transaction History